Medication info
Kaybaro Tablets 1mg (Pitavastatin Calcium Hydrate)

Kaybaro Tablets 1mg (Pitavastatin Calcium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium Hydrate›1.102mg / 1 tablet
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202102394 · Approved 2021.03.17 · Insurance code 671706880

Summary

Main use
Improvement of primary and pediatric familial hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults · Children
Adult dose
Patients taking this medicine before and during treatment must follow a standard cholesterol-lowering diet. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is inadequate, the dose may be increased to a maximum of 4 mg daily. The dose should be adjusted as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response. The therapeutic effect of this medicine is maintained with continued administration.
Child dose
Ages 10 ~ 16: Take 1 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is inadequate, the dose may be increased to a maximum of 2 mg daily.

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Improvement of primary and pediatric familial hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • increased LDL-cholesterol
  • increased apolipoprotein B
  • increased triglycerides
View approved original text

This medication helps lower total cholesterol, LDL-cholesterol, apolipoprotein B, and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia, while increasing HDL-cholesterol levels. It is also effective in pediatric patients aged 10 to 16 years with heterozygous familial hypercholesterolemia, especially when LDL-cholesterol levels are high or when there is a family history or other cardiovascular risk factors. This medicine is used as an adjunct to dietary therapy to improve blood lipid levels and reduce the risk of cardiovascular disease.

How to take

Adult dose

Patients taking this medicine before and during treatment must follow a standard cholesterol-lowering diet. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is inadequate, the dose may be increased to a maximum of 4 mg daily. The dose should be adjusted as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response. The therapeutic effect of this medicine is maintained with continued administration.

Child dose

Ages 10 ~ 16: Take 1 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is inadequate, the dose may be increased to a maximum of 2 mg daily.

Precautions

This medication should not be used in certain patients. For example, it should not be administered to patients who have allergies to this medication, severely impaired liver function, or women who are pregnant or breastfeeding. Additionally, patients with poor kidney function or liver impairment should use this drug cautiously. Since this medication is primarily metabolized in the liver, it may affect liver function. During the course of treatment, muscle-related symptoms such as myalgia or weakness may occur. If these symptoms occur, the patient should consult a doctor immediately. Since liver function abnormalities may occur, liver function tests should be performed regularly before and during treatment. If liver enzyme levels rise, discontinuation of the medication may be necessary. Platelet counts may decrease in blood tests, so it is also necessary to check blood statuses regularly. This medication may interact with other drugs, so caution is needed when taken with cyclosporine, fibrate drugs, or niacin, and co-administration should be avoided. Special care is required when administering it to elderly patients or children, as children may be at risk of muscle abnormalities depending on their activity levels and intensity, so it should be used cautiously under a doctor's instruction. Pregnant women or women who may become pregnant should not take this medication, and if pregnancy is confirmed, treatment should be discontinued immediately. While taking this medication, blood lipid levels should be monitored regularly to confirm treatment efficacy, and if there is no effect, treatment should be discontinued. This medication should be stored out of the reach of children and kept in its original container for safety. Adverse reactions during treatment may include abdominal pain, rash, fatigue, and itching, and in severe cases, serious muscle conditions such as myositis or rhabdomyolysis may occur. If these symptoms appear, the patient should inform a physician immediately and stop the treatment.

Side effects

Abdominal pain, rash, fatigue, paralysis, itching, elevated γ-GT, increased plasma creatine phosphokinase levels, elevated serum ALT, elevated serum AST, headache, myalgia, weakness, increased CPK levels, elevation of myoglobin in blood and urine, liver dysfunction, jaundice, thrombocytopenia, urticaria, erythema, angioedema, elevated bilirubin, increased cholinesterase, elevated ALP, elevated LDH, stiffness, drowsiness, insomnia, heaviness, dizziness, dry mouth, dyspepsia, abdominal bloating, constipation, stomatitis, vomiting, loss of appetite, glossitis, nausea, gastric discomfort, diarrhea, granulocytopenia, leukopenia, eosinophilia, leukocytosis, elevated globulin, positive Coombs test, anemia, polyuria, elevated BUN, increased serum creatinine, decreased aldosterone, elevated aldosterone, increased adrenocorticotropic hormone, elevated cortisol, decreased testosterone, muscle cramps, palpitations, fatigue, skin pain, burning sensation, arthralgia, edema, blurred vision, photophobia, hearing loss, hematuria, elevated uric acid levels, increased serum potassium and phosphorus, taste disturbances, colored urine, sleep disturbances, memory loss, depression, interstitial lung disease, sexual dysfunction, diabetes, immune-mediated necrotizing myopathy, myasthenia gravis, ocular myasthenia, facial edema, arm edema, hypersensitivity, skin tingling, loss of appetite, elevated blood pressure, chest discomfort, weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that does not allow light to enter. Additionally, it is advisable to store the medication at room temperature between 1 to 30 degrees Celsius. This storage method helps maintain the medication's efficacy and safety.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.